XFOR: Nilai perusahaan marang bathi resik X4 Pharmaceuticals Inc.
X4 Pharmaceuticals (XFOR) specializes in the therapy of rare immune disorders, utilizing AI and automated screening to accelerate drug discovery. This PE chart reflects a value of -4.20. The business relies on proprietary formulas with low production costs, while streamlined coordination with factories and robotic warehouses ensure the uninterrupted production and delivery of medications.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_XFOR_-_X4-Pharmaceuticals_-_PE-Multiple "XFOR: Periode bali modal bisnis X4 Pharmaceuticals 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan X4 Pharma (XFOR)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas X4 Pharmaceuticals|XFOR - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal X4 Pharmaceuticals, Inc|XFOR - Utang perusahaan|Rasio utang marang nilai buku X4 Pharmaceuticals, Inc.|XFOR - Utang jangka dawa perusahaan|Utang jangka cendhak X4 Pharmaceuticals|Rasio likuiditas darurat x4pharma.com
- rincian bathi lan kelipatan pasar:
XFOR - Bathi perusahaan|Bathi mangsa ngarep X4 Pharmaceuticals|XFOR - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep X4 Pharmaceuticals Inc.|XFOR - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA X4 Pharmaceuticals, Inc.|XFOR - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) X4 Pharmaceuticals|XFOR - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan x4pharma.com|XFOR - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep X4 Pharmaceuticals
Analisis komprehensif perusahaan:x4pharma.com XFOR
To objectively assess the issuer's value, a manager must correlate market capitalization with net income to determine the price per unit of earnings. By analyzing the annual P/E of X4 Pharmaceuticals (XFOR), an investor can identify asset overvaluation, particularly when the stock price growth of X4 Pharmaceuticals (XFOR) outpaces the actual financial gains from the commercialization of Xolremdi and the expansion of the drug's insurance coverage.
Pesaing wigati
Pangali P/E argenx.com|Koefisien rega marang bathi BNTX (BioNTech)|ABVX (ABIVAX) - Nilai perusahaan marang bathi resik|Pangali P/E ADMA (ADMA Bio)|Periode bali modal bisnis Protagonist Corp (PTGX)|IMVT - Rasio rega marang bathi|kiniksa.com (KNSA) - Koefisien rega marang bathi|Grifols (GRFS) - Rasio rega marang bathi|Koefisien rega marang bathi Adaptive Biotech|Koefisien rega marang bathi CLDX|Pangali P/E Aurinia Corp|Rasio rega marang bathi BioCryst (BCRX)|veratx.com - Pangali rega marang bathi|Pangali P/E DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalisasi marang bathi|ABCL: Koefisien rega marang bathi|TRML (Tourmaline) - Pangali rega marang bathi|Pangali rega marang bathi Precigen, Inc.|Koefisien rega marang bathi pharming.com|NKTR - Nilai perusahaan marang bathi resik|Rasio rega marang bathi UPB|ZBIO - Kapitalisasi marang bathi resik|Pangali P/E Immunome Bio (IMNM)|Nilai perusahaan marang bathi resik Gossamer Bio, Inc.|Pangali P/E kalvista.com KALV|Septerna - Pangali P/E|PVLA: Rasio rega marang bathi|Nilai perusahaan marang bathi resik Savara Corp SVRA|RIGL (Rigel Corp) - Rasio rega marang bathi|Koefisien rega marang bathi ANAB|Pangali P/E astriatx.com|Pangali P/E ENGN|Pangali P/E RAPT Therapeutics Inc. (RAPT)|Aerovate Therapeutics - Koefisien rega marang bathi|Pangali P/E Aclaris Therapeutics, Inc ACRS|KYTX (Kyverna Therapeutics) - Kapitalisasi marang bathi|tizianalifesciences.com (TLSA) - Koefisien rega marang bathi|CABA: Pangali P/E|Koefisien rega marang bathi Ventyx Biosciences Inc.|Theratechnologies Inc (THTX) - Rasio rega pasar marang bathi resik|Pangali P/E Avalo Therapeutics Inc|ELDN (Eledon Pharmaceuticals) - Periode bali modal bisnis|Pangali P/E agenusbio.com (AGEN)|Climb Bio - Koefisien rega marang bathi|Pangali P/E Zura Bio Ltd ZURA|aTyr - Pangali P/E|ADAG: Rasio rega marang bathi|ikenaoncology.com (IMA) - Rasio rega marang bathi|STTK (Shattuck Labs) - Rasio rega marang bathi|EQ: Periode bali modal bisnis|Koefisien rega marang bathi Connect Pharma (CNTB)|Pangali rega marang bathi Immunic, Inc. IMUX|Pangali P/E atarabio.com (ATRA)|InflaRx (IFRX) - Kapitalisasi marang bathi resik|Adicet Bio Inc. - Rasio rega marang bathi|CELU (Celularity Corp) - Kapitalisasi marang bathi|INMB: Rasio rega marang bathi|Nilai perusahaan marang bathi resik Barinthus Bio BRNS|KZR (Kezar Life Sciences Inc) - Rasio rega marang bathi|Kapitalisasi marang bathi resik SAB Biotherapeutics SABS|Pangali P/E akaritx.com|Enlivex Therapeutics (ENLV) - Nilai perusahaan marang bathi resik|Pangali P/E q32bio.com (QTTB)|Pangali P/E GOVX (GeoVax Labs Inc)|Edesa Biotech Corp - Rasio rega marang bathi|Nilai perusahaan marang bathi resik iBio, Inc. (IBIO)|CARM: Rasio rega marang bathi|XTLB (XTL Biopharmaceuticals Ltd.) - Koefisien rega marang bathi|Bolt Biotherapeutics, Inc. (BOLT) - Pangali P/E|HCWB (HCW Biologics, Inc.) - Pangali P/E|Koefisien rega marang bathi Aptevo (APVO)|AIM ImmunoTech Inc. (AIM) - Nilai perusahaan marang bathi resik|Pangali P/E aditxt.com (ADTX)|Periode bali modal bisnis GRI|XORTX Therapeutics Inc - Rasio rega marang bathi|HIND: Koefisien rega marang bathi|REVB: Rasio rega marang bathi|INDP (Indaptus Therapeutics) - Koefisien rega marang bathi|Koefisien rega marang bathi scinai.com|CALI (CalciMedica Inc) - Pangali P/E|Rasio rega marang bathi AFMD|Pangali rega marang bathi Allakos Inc. ALLK|Pangali P/E hookipapharma.com (HOOK)|IGMS: Kapitalisasi marang bathi|ITOS - Koefisien rega marang bathi|Ocean Biomedical (OCEA) - Pangali rega marang bathi|TCBP (TC BioPharm (Holdings) Plc) - Pangali rega marang bathi|THRD (Third Harmonic Bio, Inc) - Koefisien rega marang bathi
